SELECTIVE OMISSION OF THE DONOR CROSS-MATCH BEFORE RENAL TRANSPLANTATION

Publisher Website
Google Scholar
Abstract
Background. A donor lymphocyte cross-match (XM) test performed before renal transplantation is considered mandatory but may delay the transplant and increase the cold storage time. With careful documentation of sensitizing events and with knowledge of previous antibody screening results, it is often possible to predict the XM result for a given donor HLA mismatch. In this study, a policy was adopted of omitting the pretransplant XM in patients in whom a negative result was predicted with absolute confidence. Methods. Recipients were selected for cadaveric donor kidney transplantation using a computer algorithm based on HLA match, sensitization status, time on the waiting list and donor and recipient age. The immediate pretransplant cross-match test was omitted in non-sensitized recipients and in sensitized recipients where antibody specificities were precisely defined and not against donor HLA. Results. From October 1997 to May 1999, 53 of 96 (55%) consecutive cadaveric kidney donor transplants were performed without a pretransplant XM. In all cases, a negative donor HLA-specific antibody XM was confirmed after transplantation. Omission of the pretransplant XM was associated with a significant reduction in cold ischemic time (15.0 hr vs. 18.2 hr, P =0.01) and a reduced incidence of delayed graft function (13% vs. 33%, P =0.03). However, there was no difference in transplant outcome at 1 year. Conclusion. Rigorous attention to priming events together with careful antibody screening allows the pretransplant XM test to be safely omitted in approximately half the patients awaiting renal transplantation. This policy allows a modest reduction in cold ischemia time, but it remains to be seen whether this is of clinical benefit.